TY - JOUR
T1 - Use of dicarboxylic acid (azelaic acid) to prepare carbohydrate and protein based scaffold biopolymer with improved mechanical and thermal property for biomedical applications
AU - Gnanamani, A.
AU - Sailakshmi, G.
AU - Mitra, Tapas
PY - 2012
Y1 - 2012
N2 - Transformation of natural polymers to biopolymers for biomedical applications, face number of challenges, viz., solubility, stabilizers, strength, biocompatibility, thermal stability, etc. Hence, intensive research on suitable agents to provide the requisite properties has been initiated at global level. In the present study, an attempt was made on to engineer the Chitosan and collagen macromolecules using azelaic acid and further evaluated the thermal, mechanical and biocompatible properties of the engineered biopolymer material. Scaffold biopolymer material (3D) was prepared using Chitosan at 1.0% (w/v) and azelaic acid at 0.2% (w/v), similarly collagen 0.5% (w/v) and azelaic acid 0.2% (w/v) without using any organic solvents. Analysis revealed, the engineered materials displayed an appreciable mechanical strength and in addition found biocompatible for NIH 3T3 fibroblast cells. Studies on the chemistry behind the interaction and the characteristics of the cross-linked biopolymer materials suggested the non - covalent interactions play the major role in deciding the property of the said polymer materials and its suitability for biomedical applications.
AB - Transformation of natural polymers to biopolymers for biomedical applications, face number of challenges, viz., solubility, stabilizers, strength, biocompatibility, thermal stability, etc. Hence, intensive research on suitable agents to provide the requisite properties has been initiated at global level. In the present study, an attempt was made on to engineer the Chitosan and collagen macromolecules using azelaic acid and further evaluated the thermal, mechanical and biocompatible properties of the engineered biopolymer material. Scaffold biopolymer material (3D) was prepared using Chitosan at 1.0% (w/v) and azelaic acid at 0.2% (w/v), similarly collagen 0.5% (w/v) and azelaic acid 0.2% (w/v) without using any organic solvents. Analysis revealed, the engineered materials displayed an appreciable mechanical strength and in addition found biocompatible for NIH 3T3 fibroblast cells. Studies on the chemistry behind the interaction and the characteristics of the cross-linked biopolymer materials suggested the non - covalent interactions play the major role in deciding the property of the said polymer materials and its suitability for biomedical applications.
UR - https://www.scopus.com/pages/publications/84878312214
M3 - Article
AN - SCOPUS:84878312214
SN - 0971-1198
VL - 26
SP - 183
EP - 196
JO - Trends in Biomaterials and Artificial Organs
JF - Trends in Biomaterials and Artificial Organs
IS - 4
ER -